This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (58)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Aging/ Geriatrics  • Lipids and Lipid Disorders  • Alert me on articles by topic  Social Bookmarking   What's this?

Scott M. Grundy, MD, PhD; James I. Cleeman, MD; Basil M. Rifkind, MD; Lewis H. Kuller, MD, DrPH; for the Coordinating Committee of the National Cholesterol Education Program

Arch Intern Med. 1999;159:1670-1678.

The incidence of coronary heart disease (CHD) peaks in the elderly population. In secondary and primary prevention trials, cholesterol-lowering therapy reduces risk for CHD in both older and younger participants. This benefit, therefore, can be extended to the elderly.

From the National Cholesterol Education Program (National Heart, Lung, and Blood Institute [NHLBI]).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

ACC/AHA 2008 Performance Measures for Adults With ST-Elevation and Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for ST-Elevation and Non-ST-Elevation Myocardial Infarction) Developed in Collaboration With the American Academy of Family Physicians and American College of Emergency Physicians Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation, Society for Cardiovascular Angiography and Interventions, and Society of Hospital Medicine
Krumholz et al.
J Am Coll Cardiol 2008;52:2046-2099.
FULL TEXT  

ACC/AHA 2008 Performance Measures for Adults With ST-Elevation and Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for ST-Elevation and Non-ST-Elevation Myocardial Infarction): Developed in Collaboration With the American Academy of Family Physicians and the American College of Emergency Physicians: Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation, Society for Cardiovascular Angiography and Interventions, and Society of Hospital Medicine
WRITING COMMITTEE MEMBERS et al.
Circulation 2008;118:2596-2648.
FULL TEXT  

Metabolic Syndrome: Is It a Syndrome? Does It Matter?
Kahn
Circulation 2007;115:1806-1811.
FULL TEXT  

The Metabolic Syndrome (Emperor) Wears No Clothes
Kahn
Diabetes Care 2006;29:1693-1696.
FULL TEXT  

A Pharmacist Approach to Wellness Maintenance in the Community Elderly
Maher
Journal of Pharmacy Practice 2004;17:133-136.
ABSTRACT  

Get With the Guidelines for Cardiovascular Secondary Prevention: Pilot Results
LaBresh et al.
Arch Intern Med 2004;164:203-209.
ABSTRACT | FULL TEXT  

Primary Prevention of Coronary Heart Disease in the Elderly
Dornbrook-Lavender et al.
The Annals of Pharmacotherapy 2003;37:1654-1663.
ABSTRACT | FULL TEXT  

Task force #4--how do we select patients for atherosclerosis imaging?
Wilson et al.
J Am Coll Cardiol 2003;41:1898-1906.
FULL TEXT  

Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals
Fried et al.
J Am Coll Cardiol 2003;41:1364-1372.
ABSTRACT | FULL TEXT  

References
Circulation 2002;106:3373-3421.
FULL TEXT  

Low-Density Lipoprotein, Non-High-Density Lipoprotein, and Apolipoprotein B as Targets of Lipid-Lowering Therapy
Grundy
Circulation 2002;106:2526-2529.
FULL TEXT  

Statin Therapy in Older Persons: Pertinent Issues
Grundy
Arch Intern Med 2002;162:1329-1331.
FULL TEXT  

Therapy With Hydroxymethylglutaryl Coenzyme A Reductase Inhibitors (Statins) and Associated Risk of Incident Cardiovascular Events in Older Adults: Evidence From the Cardiovascular Health Study
Lemaitre et al.
Arch Intern Med 2002;162:1395-1400.
ABSTRACT | FULL TEXT  

Use of Cholesterol-Lowering Therapy by Elderly Adults After Myocardial Infarction
Ayanian et al.
Arch Intern Med 2002;162:1013-1019.
ABSTRACT | FULL TEXT  

Coronary Artery Calcification in Older Adults to Age 99: Prevalence and Risk Factors
Newman et al.
Circulation 2001;104:2679-2684.
ABSTRACT | FULL TEXT  

Chemopreventive Effects of Cocoa Polyphenols on Chronic Diseases
Weisburger
Exp. Biol. Med. 2001;226:891-897.
ABSTRACT | FULL TEXT  

Improving Coronary Heart Disease Risk Assessment in Asymptomatic People: Role of Traditional Risk Factors and Noninvasive Cardiovascular Tests
Greenland et al.
Circulation 2001;104:1863-1867.
FULL TEXT  

Prevention and Treatment of Coronary Heart Disease: Who Benefits?
LaRosa
Circulation 2001;104:1688-1692.
ABSTRACT | FULL TEXT  

Cholesterol lowering in the older population: time for reassessment?
Kagansky et al.
QJM 2001;94:457-463.
ABSTRACT | FULL TEXT  

Use of Lipid-Lowering Medications at Discharge in Patients With Acute Myocardial Infarction : Data From the National Registry of Myocardial Infarction 3
Fonarow et al.
Circulation 2001;103:38-44.
ABSTRACT | FULL TEXT  

Lipid-Lowering Therapy in Patients With Coronary Artery Disease: Sex or Age Bias?
Sgadari et al.
Arch Intern Med 2000;160:2684-2685.
FULL TEXT